Effectiveness of Computer-Aided Detection Chest X-Ray Screening for Improving Tuberculosis Diagnostic Yield in Chinese Primary Health Care Settings: Study Protocol for a Prospective Cluster Randomized Controlled Trial
NCT06963606 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22000
Last updated 2025-12-31
Summary
The global incidence rate and mortality of tuberculosis (TB) pose a challenge to achieving the goals set out in the tuberculosis eradication strategy and the SDGs by 2030. At present, timely and accessible early detection methods for tuberculosis are still a major obstacle. In this context, the emergence of artificial intelligence (AI), especially the AI-assisted chest X-ray (CXR) in the field of diagnostic imaging, has proved the potential to significantly improve the speed and accuracy of tuberculosis diagnosis. However, the extent to which these technologies can affect the broader tuberculosis care cascade, especially by reducing the diagnostic time in the population level, has not yet been explored. The proposed project plans to use the certified AI-assisted CXR system (JF CXR-1) for tuberculosis screening, which aims not only to integrate AI into the diagnosis process, but also to critically assess its impact on the overall tuberculosis care cascade. The selected location for this project is Yichang City in western Hubei Province, China, which is facing a high TB burden. The city has established a strong city-wide health big data platform ten years ago, providing the basis for this project. The project will first optimize the AI-assisted CXR system through retrospective imaging to validate the accuracy of case screening (Stage Ⅰ). Secondly, the project will shift its focus to the real world, where cluster randomized controlled trials will be conducted in primary-care settings (Stage Ⅱ). In this stage, the effectiveness of the AI-assisted CXR system in reducing the diagnostic time of TB cases will be evaluated by comparing with those settings without using the tool. In stage Ⅲ, the qualitative and quantitative methods will be used to evaluate the generalization, practicality, and feasibility of extending the screening strategy in various community environments. If the AI-assisted screening strategy is proven accurate, effective, and sustainable, it may pave the way for its widespread adoption in primary healthcare institutions and other grassroots areas in China. This can not only improve the timeliness of tuberculosis diagnosis, but also help to allocate medical resources more effectively and significantly reduce tuberculosis-related incidence and mortality, bringing positive changes to global public health. In addition, the results of the project can also provide information for policy decisions and guide the formulation of strategies to prioritize the integration of AI into health care, which can not only fight against tuberculosis but also a series of other diseases.
Conditions
- Tuberculosis (TB)
Interventions
- DIAGNOSTIC_TEST
-
Artificial intelligence-assisted chest X-ray in TB screening
After the completion of the chest DR Examination, the chest X-ray was analyzed by the artificial intelligence-assisted system (JF CXR-1) to identify the potential signs of tuberculosis. Meanwhile, the doctor analyzed the results of the chest X-ray. After the analysis results were confirmed, the initial judgment results of the doctor and the analysis results of the artificial intelligence-assisted system were recorded, and the reading results of the artificial intelligence-assisted system were fed back to the doctor. Review the doctor's comprehensive analysis results of the artificial intelligence-assisted system, make a final judgment on the chest X-ray results, and determine whether further relevant examinations (such as etiological examination, CT examination, etc.) are needed. Record the doctor's judgment results. Follow up and record the time of diagnosis reported by the tuberculosis specific disease system.
- OTHER
-
Routine doctors analyze the process of chest X-rays
After the chest DR Examination is completed, a regular doctor reviews the films without using an artificial intelligence-assisted system. Once the results of the regular doctor's review are confirmed, a final judgment is made on whether further related examinations (such as etiological tests, CT scans, etc.) are needed, and the doctor's judgment is recorded. Follow up and record the time of diagnosis reported by the tuberculosis specific disease system
Sponsors & Collaborators
-
China Medical Board (CMB)
collaborator UNKNOWN -
Yichang Center for Disease Control and Prevention, China
collaborator UNKNOWN -
JF Intelligent Healthcare Medical Technology Co
collaborator UNKNOWN -
Xuelin Yang
lead OTHER
Principal Investigators
-
Wang Ye Prof · chool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-09-01
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- China
Study Locations
More Related Trials
-
Delayed Diagnosis of Bacteriologically Positive Pulmonary Tuberculosis and Relative Optimized Suggestions in China
NCT04434976 ·Status: COMPLETED
-
Acceptability and Feasibility of Home-based TB Testing
NCT04973371 ·Status: COMPLETED ·Phase: NA
-
Self-verification and Support Via Mobile Phones Drastically Improves Tuberculosis Treatment Success in LMIC Settings
NCT03135366 ·Status: COMPLETED ·Phase: NA
-
A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2
NCT04766307 ·Status: UNKNOWN ·Phase: PHASE4
-
Application of GeneXpert on Bronchoscopic Samples for Patients Suspicious of TB
NCT02838641 ·Status: COMPLETED
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
Ultra-Short Regimen for Elderly DS-TB
NCT07076225 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Plasma MTB cfDNA Before Bronchoscopy
NCT07230457 ·Status: NOT_YET_RECRUITING
-
Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19
NCT05220163 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
NCT04148053 ·Status: UNKNOWN
-
Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis
NCT02776150 ·Status: UNKNOWN
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
NCT06033807 ·Status: RECRUITING
-
Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB
NCT02619240 ·Status: COMPLETED
-
Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein
NCT05746611 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of CAD-based Triage for CXR Interpretation During TB Screening
NCT06401434 ·Status: COMPLETED ·Phase: NA
-
Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts
NCT02454738 ·Status: COMPLETED ·Phase: NA
-
Effect of Community Active Case Finding Strategies for Detection of Tuberculosis in Cambodia
NCT04094350 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis
NCT04666311 ·Status: COMPLETED
-
Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above
NCT07152639 ·Status: RECRUITING ·Phase: PHASE3
-
"Conducting A Study On Video Observed Therapy In The Management Of Tuberculosis"
NCT05994144 ·Status: UNKNOWN ·Phase: NA
-
Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment
NCT02810678 ·Status: COMPLETED ·Phase: NA
-
NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
NCT02371681 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis
NCT01600963 ·Status: WITHDRAWN ·Phase: PHASE3
-
Pharmacist-Led Intervention to Improve TB Treatment Adherence
NCT06608069 ·Status: COMPLETED ·Phase: NA